Epoetin beta

Epoetin beta
Clinical data
AHFS/Drugs.com International Drug Names
ATC code B03XA01 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
ChemSpider none
UNII 64FS3BFH5W N
 NYesY (what is this?)  (verify)

Epoetin beta (rINN) /ɛˈp.tn/ is a synthetic, recombinant[1] form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.

Epoetin is marketed under the trade names NeoRecormon.[2]

References

  1. Dunn CJ, Markham A (1996). "Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure". Drugs. 51 (2): 299–318. doi:10.2165/00003495-199651020-00008. PMID 8808169.
  2. Amgen - Products. URL: http://www.amgen.com/patients/prca.html. Accessed on: October 21, 2007.


This article is issued from Wikipedia - version of the 9/1/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.